{"symbol": "AKTX", "companyName": "Akari Therapeutics Plc", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.akaritx.com", "description": "Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.", "CEO": "Clive Richardson", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}